Position Your Solutions as Essential: Become the Go-To Partner for mRNA Leaders Driving the Future of Scalable, Compliant mRNA Therapeutics and Vaccines.
With global investment accelerating across saRNA, circRNA, personalized cancer vaccines, and gene editing, the mRNA field is rapidly evolving. Companies are under increasing pressure to deliver robust, scalable, and regulatory-ready platforms that can meet growing clinical and commercial demands.
Process development and CMC leaders have made one thing clear, without trusted partners, mRNA production is impossible. The industry experts who shaped this agenda asked for dedicated discussions on choosing the right collaborators, technologies, and services.
This makes the 4th mRNA Process Development & CMC Summit your unmissable opportunity to position your solutions as must-have for success.
Returning to Boston this September, the summit is the flagship forum for 175+ mRNA developers to solve technical bottlenecks, improve efficiency, and secure approvals. With confirmed participation from Moderna, Sanofi, BioNTech, CureVac, AstraZeneca, GSK, CSL, CEPI, and US Pharmacopeia, you’ll gain direct access to senior decision-makers in CMC, MS&T, QA/QC, regulatory, and manufacturing.
If you have services in:
Then this is your opportunity to stand out in front of hyper-relevant buyers who are actively refining their platforms, building next-gen mRNA programs, and accelerating safe, compliant mRNA therapies to patients.
Why Partner:
Leverage Unfiltered Market Intelligence
Hear directly from senior CMC, MS&T, and QA/QC leaders from Moderna, BioNTech, Sanofi, AstraZeneca, CureVac and more as they reveal where gaps remain across DNA sourcing, IVT, analytics, purification, and regulatory readiness - allowing you to position your solution exactly where the need is greatest.
Showcase High-Impact Technical Solutions
Whether you provide enzymes, LNPs, in-line analytics, digital twins, lyophilization tech, or regulatory strategy consulting, this summit puts your offering in front of hyper relevant, decision-makers responsible for vendor selection in clinical and commercial-scale mRNA programs.
Engage Buyers at Their Moment of Need
Each session is built around solving a high-priority bottleneck, from dsRNA removal to platform comparability. You’ll know exactly who’s in the room and can use our structured networking tools to forge targeted, high-value commercial connections that drive client growth.
In 2024, Sponsors Networked With:
